Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis by Tabrizi, Sarah J, Prof, Scahill, Rachael I, PhD, Durr, Alexandra, MD, Roos, Raymund AC, MD, Leavitt, Blair R, FRCPC, Jones, Rebecca, MSc, Landwehrmeyer, G Bernhard, MD, Fox, Nick C, MD, Johnson, Hans, PhD, Hicks, Stephen L, PhD, Kennard, Christopher, FRCP, Craufurd, David, FRCPsych, Frost, Chris, PhD, Langbehn, Douglas R, MD, Reilmann, Ralf, MD, Stout, Julie C, PhD

Get full text

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial by de Yebenes, Justo Garcia, Dr, Landwehrmeyer, Bernhard, MD, Squitieri, Ferdinando, MD, Reilmann, Ralf, MD, Rosser, Anne, MD, Barker, Roger A, MD, Saft, Carsten, MD, Magnet, Markus K, MD, Sword, Alastair, MSc, Rembratt, Åsa, PhD, Tedroff, Joakim, MD

Get full text